Joanna Gell, md
Understanding how germ cell tumors arise is tricky since these tumors start very early in life; perhaps even in utero. A creative physician-scientist at UCLA.,Dr. Joanna Gell has helped developed a new way to study these tumors using stem cells. With a greater understanding of how these tumors form, new therapies to treat this cancer […]
Kathryn Lemberg, md, phd
Dr. Lemberg is a pediatric oncologist and lab researcher at John’s Hopkins University School of Medicine. She just received her second year of funding from Pablove to continue researching a novel therapy for Malignant Peripheral Nerve Sheath Tumors. Her project focuses on a novel agent developed at John’s Hopkins that works differently than conventional chemotherapy, […]
W. Clay Gustafson, md, phd
At University of California San Francisco, Dr.Clay Gustafson is tackling some of the most difficult to treat pediatric cancers; tumors such as neuroblastoma that are driven by the MYC family of proteins. Dr. Gustafson’s Powered by Pablove Seed Grant will allow him to explore a new therapy that shows great promise for treating these tumors. […]
Christopher Ott, Ph.D.
Dr. Ott is a bright junior investigator at Massachusetts General Hospital. The aim of his Powered by Pablove seed grant project is to identify proteins critical for the survival of T-cell Leukemia cells as well as new drug agents that can be effective in treating this difficult disease.